Literature DB >> 14618620

A-kinase anchoring protein 3 messenger RNA expression in ovarian cancer and its implication on prognosis.

Kosei Hasegawa1, Toshiro Ono, Hirokazu Matsushita, Michihide Shimono, Yuji Noguchi, Yasushi Mizutani, Junichi Kodama, Takafumi Kudo, Eiichi Nakayama.   

Abstract

A-kinase anchoring protein 3 (AKAP3) is a sperm protein and its expression appears to be restricted to the testis in normal adult tissues. We investigated AKAP3 mRNA expression in 20 normal ovaries and 54 ovarian cancers of different histological types, grades and stages by reverse transcription-polymerase chain reaction (RT-PCR). The PCR products were analyzed by conventional agarose gel electrophoresis and capillary electrophoresis on a microtip device to determine the expression semiquantitatively. Little or no expression was observed in the 20 normal ovarian specimens. High AKAP3 mRNA expression was observed in 15 ovarian cancer specimens (28 %). The expression was correlated with the histological grade and clinical stage. AKAP3 mRNA was observed at a significantly higher frequency in poorly differentiated (p = 0.009) and advanced stage (III and IV, p = 0.014) tumors. No correlation was found between AKAP3 mRNA expression and other variables. In Cox multivariate analysis, AKAP3 mRNA expression was found to be a significant predictor of both overall and progression-free survival in patients with poorly differentiated tumors. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14618620     DOI: 10.1002/ijc.11565

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

Review 1.  A-kinase anchoring proteins: cAMP compartmentalization in neurodegenerative and obstructive pulmonary diseases.

Authors:  W J Poppinga; P Muñoz-Llancao; C González-Billault; M Schmidt
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

2.  Protein kinase A activity and anchoring are required for ovarian cancer cell migration and invasion.

Authors:  Andrew J McKenzie; Shirley L Campbell; Alan K Howe
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

3.  Protein Kinase A-induced tamoxifen resistance is mediated by anchoring protein AKAP13.

Authors:  Cristiane Bentin Toaldo; Xanthippi Alexi; Karin Beelen; Marleen Kok; Michael Hauptmann; Maurice Jansen; Els Berns; Jacques Neefjes; Sabine Linn; Rob Michalides; Wilbert Zwart
Journal:  BMC Cancer       Date:  2015-08-14       Impact factor: 4.430

Review 4.  Factors and pathways involved in capacitation: how are they regulated?

Authors:  Shi-Kai Jin; Wan-Xi Yang
Journal:  Oncotarget       Date:  2017-01-10

5.  Serological identification of Tektin5 as a cancer/testis antigen and its immunogenicity.

Authors:  Tadashi Hanafusa; Ali Eldib Ali Mohamed; Shohei Domae; Eiichi Nakayama; Toshiro Ono
Journal:  BMC Cancer       Date:  2012-11-14       Impact factor: 4.430

6.  The cancer-testis antigen a-kinase anchor protein 3 facilitates breast cancer progression via activation of the PTEN/PI3K/AKT/mTOR signaling.

Authors:  Chuan-Hua Zhan; Dong-Shen Ding; Wei Zhang; Hong-Liang Wang; Zhe-Yu Mao; Guo-Jun Liu
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.